** Shares of drug developer Wave Life Sciences WVE.O rise 4.5% to $10.50 premarket

** Co reports Q4 diluted income per share of 18 cents, compared with loss of 15 cents a year ago

** WVE posts Q4 revenue of $83.7 million vs $29.1 million a year earlier

** As of last close, stock is down 18.8% YTD

(Reporting by Jaiveer Singh Shekhawat in Bengaluru)

((JaiveerSingh.Shekhawat@thomsonreuters.com;))